Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authorsvan den Wijngaard, Cees C
Harms, Margriet G
de Wit, G Ardine
Lugnér, Anna K
Suijkerbuijk, Anita W M
Mangen, Marie-Josée J
van Pelt, Wilfrid
MetadataShow full item record
TitleThe cost of Lyme borreliosis.
Published inEur J Public Health 2017; 27(3):538-47
PubliekssamenvattingLyme borreliosis (LB) is the most frequently reported tick-borne infection in Europe and North America. The aim of this study was to estimate the cost-of-illness of LB in the Netherlands. We used available incidence estimates from 2010 for tick bite consultations and three symptomatic LB outcomes: erythema migrans (EM), disseminated LB and Lyme-related persisting symptoms. The cost was estimated using these incidences and the average cost per patient as derived from a patient questionnaire. We estimated the cost from a societal perspective, including healthcare cost, patient cost and production loss, using the friction cost method and a 4% annual discount rate. Tick bites and LB in 2010 led to a societal cost of €19.3 million (95% CI 15.6-23.4; 16.6 million population) for the Netherlands. Healthcare cost and production loss each constituted 48% of the total cost (€9.3 and €9.2 million/year), and patient cost 4% (€0.8 million/year). Of the total cost, 37% was related to disseminated LB, followed by 27% for persisting symptoms, 22% for tick bites and 14% for EM. Per outcome, for an individual case the mean cost of disseminated LB and Lyme-related persisting symptoms was both around €5700; for EM and GP consultations for tick bites this was €122 and €53. As an alternative to the friction cost method, the human capital method resulted in a total cost of €23.5 million/year. LB leads to a substantial societal cost. Further research should therefore focus on additional preventive interventions.
- The burden of Lyme borreliosis expressed in disability-adjusted life years.
- Authors: van den Wijngaard CC, Hofhuis A, Harms MG, Haagsma JA, Wong A, de Wit GA, Havelaar AH, Lugnér AK, Suijkerbuijk AW, van Pelt W
- Issue date: 2015 Dec
- Decrease in tick bite consultations and stabilization of early Lyme borreliosis in the Netherlands in 2014 after 15 years of continuous increase.
- Authors: Hofhuis A, Bennema S, Harms M, van Vliet AJ, Takken W, van den Wijngaard CC, van Pelt W
- Issue date: 2016 May 23
- Continuing increase of tick bites and Lyme disease between 1994 and 2009.
- Authors: Hofhuis A, Harms M, van den Wijngaard C, Sprong H, van Pelt W
- Issue date: 2015 Feb
- Physician reported incidence of early and late Lyme borreliosis.
- Authors: Hofhuis A, Harms M, Bennema S, van den Wijngaard CC, van Pelt W
- Issue date: 2015 Mar 15
- Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015-2017.
- Authors: Geebelen L, Van Cauteren D, Devleesschauwer B, Moreels S, Tersago K, Van Oyen H, Speybroeck N, Lernout T
- Issue date: 2019 Apr